Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Effectiveness of the ATC System in the Treatment of Acute PE

NCT: NCT06152341 · SUSPENDED

NCT IDNCT06152341
StatusSUSPENDED
Start Date2024-05-15
Completion2027-05
SponsorAkura Medical (INDUSTRY)
First posted
Last updated

Brief Summary

This study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of the ATC System in subjects with acute pulmonary embolism (PE).

Frequently Asked Questions

What is Safety and Effectiveness of the ATC System in the Treatment of Acute PE?

Safety and Effectiveness of the ATC System in the Treatment of Acute PE is a clinical trial registered under NCT06152341. Current status: SUSPENDED.

What is the status of NCT06152341?

The current status of NCT06152341 (Safety and Effectiveness of the ATC System in the Treatment of Acute PE) is: SUSPENDED.

When did Safety and Effectiveness of the ATC System in the Treatment of Acute PE start?

Safety and Effectiveness of the ATC System in the Treatment of Acute PE started on 2024-05-15.

Related Devices

K251070Akura Thrombectomy SystemAkura Medical

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑